<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211122053149N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-18</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Efficacy of pure xenografts in bone augmentation</public_title>
      <acronym></acronym>
      <scientific_title>Efficacy of xenograft materials in maxillary edentulous ridge augmentation: a clinical study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72304</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment.</study_design>
      <phase>2</phase>
      <hc_freetext>Horizontal defect in maxillary ridge.</hc_freetext>
      <i_freetext>Local anesthesia is administered in the maxilla by injection of 4% articaine plus 1:100,000 epinephrine. A mid-crestal incision is made from the most anterior tooth to 5 mm beyond the augmentation area using a 15c surgical scalpel. An oblique releasing incision is made at the mesial end of the first incision and extended beyond the mucogingival line. A full-thickness flap is reflected using a periosteal elevator. In case of requiring maxillary sinus floor augmentation, the lateral window is outlined with a 5 mm distance from the floor and anterior wall of the sinus by piezosurgery. Intentional perforation of cortical bone of the edentulous ridge is performed at 5 mm intervals using a round diamond bur. A barrier membrane of natural collagen (Bio-Gide, Geistlich Biomaterials, Switzerland) is prepared to correspond to the dimensions of the augmentation site and fixed in the most apical part of the vestibular region by using fixation tacks. Bovine xenograft material (Bio-Oss, Geistlich Biomaterials, Switzerland) is hydrated with sterile saline and applied in the sinus cavity and over the lateral wall of the edentulous ridge. The barrier membrane is extended over the crest to cover the palatal wall of the ridge and fixed in place using additional tacks. The flap is released with periosteal-releasing incisions at the flap base, and also by releasing muscle attachments at the vestibular side. The flap margins are coronally displaced with tension-free mattress sutures (poly-glycolic acid). Additional simple sutures are applied to ensure complete sealing of the incision site. Oblique incisions are approximated by using simple single sutures. The sutures are removed after 2 weeks, and the patients are instructed to refrain from using a removable partial denture during the healing period. A minimum of 6 months after surgery, CBCT of the augmented area is requested and the treatment results are assessed..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Anahita Moscowchi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshjoo Blvd, Evin, Chamran Hwy</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983963113</zip>
        <telephone>+98 21 2990 2314</telephone>
        <email>a.moscowchi@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Anahita Moscowchi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshjoo Blvd, Evin, Chamran Hwy</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983963113</zip>
        <telephone>+98 21 2990 2314</telephone>
        <email>a.moscowchi@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Partial/complete edentulism of the maxillary ridge with or without the need for maxillary sinus floor augmentation
Patients requiring implant-supported fixed dentures
Availability of follow-up data of patients for a minimum of 6 months after edentulous ridge augmentation.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Smoking
Alcohol consumption
Substance abuse
Uncontrolled metabolic disorders
Untreated periodontal disease
History of radiotherapy or intake of immunosuppressants
History of intake of anti-resorptive medications</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Local anesthesia is administered in the maxilla by injection of 4% articaine plus 1:100,000 epinephrine. A mid-crestal incision is made from the most anterior tooth to 5 mm beyond the augmentation area using a 15c surgical scalpel. An oblique releasing incision is made at the mesial end of the first incision and extended beyond the mucogingival line. A full-thickness flap is reflected using a periosteal elevator. In case of requiring maxillary sinus floor augmentation, the lateral window is outlined with a 5 mm distance from the floor and anterior wall of the sinus by piezosurgery. Intentional perforation of cortical bone of the edentulous ridge is performed at 5 mm intervals using a round diamond bur. A barrier membrane of natural collagen (Bio-Gide, Geistlich Biomaterials, Switzerland) is prepared to correspond to the dimensions of the augmentation site and fixed in the most apical part of the vestibular region by using fixation tacks. Bovine xenograft material (Bio-Oss, Geistlich Biomaterials, Switzerland) is hydrated with sterile saline and applied in the sinus cavity and over the lateral wall of the edentulous ridge. The barrier membrane is extended over the crest to cover the palatal wall of the ridge and fixed in place using additional tacks. The flap is released with periosteal-releasing incisions at the flap base, and also by releasing muscle attachments at the vestibular side. The flap margins are coronally displaced with tension-free mattress sutures (poly-glycolic acid). Additional simple sutures are applied to ensure complete sealing of the incision site. Oblique incisions are approximated by using simple single sutures. The sutures are removed after 2 weeks, and the patients are instructed to refrain from using a removable partial denture during the healing period. A minimum of 6 months after surgery, CBCT of the augmented area is requested and the treatment results are assessed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Buccolingual width of the ridge at the level of 2 mm apical to the alveolar crest. Timepoint: Measurement of ridge width at the beginning of treatment and at least 6 months after surgery. Method of measurement: Cone beam computed tomography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Ridge height based on a fixed point on the nasal floor or sinus floor. Timepoint: At the beginning of treatment and at least 6 months after surgery. Method of measurement: Cone beam computed tomography.</sec_outcome>
      <sec_outcome>Height increase in the sinus area in cases where sinus augmentation would also been performed. Timepoint: At the beginning of treatment and at least 6 months after surgery. Method of measurement: Cone beam computed tomography.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-01</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Daneshjoo Blv., Evin, Shahid Chamran Hwy Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
